| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |